Premium Vadadustat API in Pakistan: Reliable Raw Material Supply for Pharmaceutical Formulators

Product Name: Vadadustat (Active Pharmaceutical Ingredient)

Supplier / Distributor: Morgan

Therapeutic Category: Hypoxia-Inducible Factor Prolyl Hydroxylase (HIF-PH) Inhibitor

Indications: Symptomatic Anemia associated with Chronic Kidney Disease (CKD)

Compliance Notice: This technical data page is strictly for B2B pharmaceutical manufacturers, contract manufacturing organizations (CMOs), and analytical laboratories. The Vadadustat distributed by Morgan is a highly purified Active Pharmaceutical Ingredient (API) intended exclusively for commercial formulation and laboratory R&D. It is not a finished drug product.

About Morgan: Morgan Chemicals (Pvt.) Ltd. is a pharmaceutical raw material trading and distribution company. We source APIs from DRAP-registered and internationally certified manufacturers and supply exclusively to licensed pharmaceutical companies, CMOs, and research facilities. We do not manufacture APIs or sell finished medicines.

Product Overview and Mechanism of Action

Vadadustat is an orally bioavailable, small-molecule Active Pharmaceutical Ingredient (API). In renal and hematological pharmacology, it is classified as a hypoxia-inducible factor prolyl hydroxylase (HIF-PH) inhibitor. For pharmaceutical manufacturers, this API represents a major shift in the treatment paradigm for renal anemia, offering an oral alternative to traditional injectable erythropoiesis-stimulating agents (ESAs).

The physiological mechanism of Vadadustat leverages the body's natural response to hypoxia (low oxygen levels). Under normal oxygen conditions, HIF prolyl hydroxylase enzymes quickly degrade hypoxia-inducible factors (HIF-1α and HIF-2α). By reversibly inhibiting these specific prolyl hydroxylase enzymes, Vadadustat stabilizes the HIF transcription factors.

This stabilization initiates a coordinated physiological response that mimics the body's adaptation to high altitudes. It stimulates the endogenous production of erythropoietin (EPO) in the kidneys and liver, suppresses hepcidin to improve iron mobilization, and ultimately drives red blood cell production (erythropoiesis). For formulation scientists, integrating this API enables the development of highly effective oral therapeutics targeted at restoring and maintaining hemoglobin levels in patients undergoing chronic maintenance dialysis. In finished pharmaceutical products, Vadadustat is typically formulated into immediate-release oral solid dosage forms.

Sourcing Vadadustat in Pakistan: Morgan’s Supply Network

Developing and commercializing advanced hematological formulations requires a highly resilient and traceable raw material pipeline. Procuring specialty APIs for local commercial manufacturing frequently involves navigating extended lead times, stringent customs bottlenecks, and highly complex regulatory compliance. Sourcing Vadadustat Pakistan through Morgan’s localized distribution network mitigates these complex supply chain risks.

Morgan sources commercial-scale and pilot-scale quantities from global manufacturing partners operating in strict adherence to ICH Q7 Good Manufacturing Practice (GMP) guidelines. Partnering with Morgan as your primary supply vendor secures several operational provisions for your manufacturing facility:

• DRAP Submission Assistance: Morgan coordinates with DRAP-registered API manufacturers to obtain and forward the necessary compliance documentation on your behalf. This includes the open part of the Drug Master File (DMF), comprehensive impurity profiles, and accelerated stability data to strictly support your Drug Regulatory Authority of Pakistan (DRAP) dossier submissions.
• Supply Chain Stability: Our localized API inventory management eliminates international transit variables. Whether you require a standard batch or are scaling up a high-volume Vadadustat api Pakistan procurement order, we help ensure that your commercial batch schedules and production timelines are met without costly line stoppages or raw material shortages.
• Batch-to-Batch Uniformity: Every shipment coordinated by Morgan includes a detailed Certificate of Analysis (CoA) issued by the original manufacturer. We ensure our supplied batches maintain consistent chemical purity, controlled moisture limits, and a precise particle size distribution (PSD) for predictable behavior during blending and tablet compression processes.

Technical Specifications for QA & R&D

The Vadadustat API supplied by Morgan undergoes exacting analytical testing at the source to meet current international pharmacopeial standards.

• Chemical Name: 2-[[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino]acetic acid
• CAS Number: 1000025-07-9
• Appearance: White to off-white crystalline solid powder
• Molecular Formula: C14H11ClN2O4
• Molecular Weight: 306.7 g/mol
• Assay / Purity (HPLC): ≥ 99.0%
• Solubility Profile: Detailed solubility parameters across standard organic solvents and aqueous buffers of varying pH levels are documented in the technical data sheet to assist your analytical R&D teams with dissolution profiling and pre-formulation stability studies.

Manufacturing and Handling Guidelines for Formulators

Vadadustat is a pharmacologically active compound that directly influences systemic red blood cell production and iron metabolism. Facilities processing this API must enforce strict occupational exposure limits (OEL) to protect personnel on the manufacturing floor.

• Storage Conditions: Store the raw API powder in securely closed, light-resistant containers. Maintain climate-controlled conditions as specified by the batch protocol (typically controlled room temperature, strictly protected from excessive heat and ambient humidity) to prevent degradation and maintain structural integrity.
• Occupational Safety: Personnel handling the pure API powder must follow advanced industrial containment protocols. Processing requires appropriate Personal Protective Equipment (PPE), including P3/N95 industrial dust masks or respirators, chemical-resistant nitrile gloves, and full protective facility garments. Dispensing, milling, and compounding stages must be executed within localized exhaust ventilation systems or dedicated negative-pressure weighing booths to prevent the inhalation of airborne particulates and facility cross-contamination.

Distributor Disclaimer: Morgan Chemicals is a pharmaceutical raw material trading and distribution company. This API is sourced from DRAP-registered, GMP-certified manufacturing partners. Morgan Chemicals does not manufacture APIs, does not hold DRAP manufacturing registration, and does not sell finished medicines. This product is supplied exclusively to licensed pharmaceutical companies, CMOs, and research facilities in Pakistan — not for individual or consumer sale.